98% of Cancer Patients Outside the US Miss Genomic Testing. Can AI Change That?
In this episode of Diagnosing Dx, David Filby is joined by Travis Wold, Chief Executive Officer at Imagenomix.
Travis brings experience across cancer diagnostics, genomics, liquid biopsy, and international commercialization. We explore how Imagenomix is using AI to help make genomic testing more accessible to cancer patients globally.
With around 98% of cancer patients outside the US not receiving NGS testing, Travis explains how analysing standard H&E pathology images could help identify patients who are more likely to benefit from confirmatory genomic testing.
We also discuss Imagenomix’s…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.